The North American Biopsy Devices Market size was worth USD 649.34 million in 2023 and is estimated to be growing at a CAGR of 6.82% to reach USD 903.09 million by 2028. North America holds the most significant share in the global biopsy device market due to the increasing geriatric population.
The growing number of cancer patients in North America primarily drive the North American biopsy devices market growth. The rising demand for biopsy devices to diagnose cancer cells is prompting the market demand. A biopsy is a procedure to remove a piece of tissue from the body. Some common types of biopsies are breast biopsy, prostate biopsy, liver biopsy, hat biopsy, skin biopsy, etc. Several laboratory tests have been done samples for the determination of the issue. In the healthcare sector, imaging tests such as CT and MRI are used for detecting masses and irregular tissue, but they cannot determine whether it is cancerous cells. As a result, healthcare providers prefer the biopsy procedure, which is done using biopsy devices to help with market demand. A biopsy is also used to detect infections, such as tuberculosis, and immune disorders, such as chronic pancreatic, ulcer, and endometriosis.
The rising preference for minimal invasion surgeries contributes to the biopsy devices market growth in North America. Due to fewer cuts and less blood flow, patients are adopting minimal invasion surgery. It also takes less operational time, fewer hospital stays, and less recovery time. In recent years, most of the geriatric population are adopting minimal invasion surgery to detect cancer through biopsy. Biopsy devices are also used in surgical procedures in the removal of tissue for the further detection process.
The growing number of advancements in the manufacturing of biopsy devices and increasing R&D activities around biopsy devices supports the North American market growth. Manufacturers are focused on the development of various types of needles that are used during biopsy procedures. Needle plays a major role in the removal of required tissue for the detection of cancer. They also focus on developing biopsy instruments and automation equipment, which reduce human errors during the surgical procedure. Increasing use of advanced technologies in manufacturing devices, increasing support of healthcare organizations, and increasing presence of key players will fuel the market growth in the coming years.
The high cost of the biopsy device primarily hinders the North American market growth. Lack of awareness about the procedures, high cost of the biopsy procedures, and lack of skilled professionals further impedes the market growth in North America.
This research report on the North American Biopsy Devices Market has been segmented & sub-segmented into the following categories:
By End User:
North America held the largest share of the worldwide market in 2022 and is expected to continue the domination throughout the forecast period owing to the presence of advanced medical devices in the healthcare sector and the increasing healthcare expenditure by the population. The government has followed several measures to approve and launch the novel biopsy device to reduce errors during surgical procedures.
The U.S. led the market in North America in 2022 and is expected to continue the lead in the coming years due to the presence of manufacturing centers and the increasing presence of key players. Increasing numbers of specialized professionals, increasing the number of diagnostic centers and pathology centers, and increasing cancer hospitals are the other factor that raises the market demand. For instance, nearly 1.9 million new cancer cases have reported in the United States region in 2021.
Canada is estimated to witness a healthy CAGR in the coming years. Factors such as the increasing number of clinical trial centers and increasing reimbursement policies for surgeries drivee the Canadian market growth. Canada's government has conducted several awareness programs about the biopsy procedure, which helps detect cancer or noncancerous cell for early prevention of the diseases.
Companies playing a dominating role in the North American biopsy devices market are Medtronic, Leica Biosystems, Hologic Inc., Boston Scientific Corporation, Becton, Cook Medical Inc., C.R. Bard Inc., Mauna Kea Technologies, Ethicon EndoSurgery Inc., Veran Medical Technologies, Dickinson and Company, Fujifilm Medical Systems, MDxHealth, Argon Medical Devices Inc and Intact Medical Corp.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org